Page last updated: 2024-10-23

bromhexine and Bacterial Infections

bromhexine has been researched along with Bacterial Infections in 4 studies

Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).

Bacterial Infections: Infections by bacteria, general or unspecified.

Research Excerpts

ExcerptRelevanceReference
"In a 6-month, double-blind multicenter trial conducted over the winter, the effects of daily administration of ambroxol retard (75 mg) were compared with those of placebo in preventing exacerbations and improving symptoms and clinical signs in chronic bronchitis patients."9.06Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo. ( Bonsignore, G; Carnimeo, N; Catena, E; Chianese, R; Daniotti, S; Ferrara, G; Marcatili, S; Olivieri, D; Tomasini, G; Zavattini, G, 1987)
"In a 6-month, double-blind multicenter trial conducted over the winter, the effects of daily administration of ambroxol retard (75 mg) were compared with those of placebo in preventing exacerbations and improving symptoms and clinical signs in chronic bronchitis patients."5.06Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo. ( Bonsignore, G; Carnimeo, N; Catena, E; Chianese, R; Daniotti, S; Ferrara, G; Marcatili, S; Olivieri, D; Tomasini, G; Zavattini, G, 1987)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deretic, V1
Timmins, GS1
Palmieri, B1
Monni, S1
Misella, A1
Cogni, P1
Turco, P1
Pomari, C1
Zoccatelli, O1
Trevisan, F1
Carloni, C1
Dal Negro, RW1
Olivieri, D1
Zavattini, G1
Tomasini, G1
Daniotti, S1
Bonsignore, G1
Ferrara, G1
Carnimeo, N1
Chianese, R1
Catena, E1
Marcatili, S1

Reviews

1 review available for bromhexine and Bacterial Infections

ArticleYear
Enhancement of lung levels of antibiotics by ambroxol and bromhexine.
    Expert opinion on drug metabolism & toxicology, 2019, Volume: 15, Issue:3

    Topics: Ambroxol; Animals; Anti-Bacterial Agents; Bacterial Infections; Bromhexine; Drug Resistance, Bacteri

2019

Trials

1 trial available for bromhexine and Bacterial Infections

ArticleYear
Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo.
    Respiration; international review of thoracic diseases, 1987, Volume: 51 Suppl 1

    Topics: Adult; Ambroxol; Bacterial Infections; Bromhexine; Bronchitis; Chronic Disease; Clinical Trials as T

1987

Other Studies

2 other studies available for bromhexine and Bacterial Infections

ArticleYear
Therapeutic and prophylactic effects of cephalexin and bromhexine in respiratory tract complications of abdominal surgery.
    International journal of clinical pharmacology, therapy, and toxicology, 1983, Volume: 21, Issue:3

    Topics: Abdomen; Adult; Aged; Bacterial Infections; Bromhexine; Cephalexin; Drug Therapy, Combination; Femal

1983
Therapy for intercurrent respiratory infections in COLD patients: report on 200 patients.
    International journal of clinical pharmacology, therapy, and toxicology, 1983, Volume: 21, Issue:5

    Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Bromhexine; Cephalexin; Drug Therapy, Combi

1983